We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Seeks To Fracture Class In Bone Drug Suit

Law360 (August 13, 2007, 12:00 AM EDT) -- Locked in a battle over bone cancer drugs Aredia and Zometa, Novartis Pharmaceutical Corp. has asked the district judge overseeing the multidistrict product liability litigation to break apart a current class...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.